TMCnet News
IMPORTANT INVESTOR NOTICE: Lundin Law PC Announces Ongoing Investigation of Anavex Life Sciences Corp. and Urges Investors with Losses in Excess of $250,000 to Contact the FirmLundin Law PC announces it is investigating claims against Anavex Life Sciences Corp. ("Anavex" or the "Company") (Nasdaq: AVXL) concerning possible violations of federal securities laws. The investigation is related to allegations that certain statements issued by Anavex were false and misleading and/or failed to disclose material information regarding the Company's financial performance. To participate in this lass action lawsuit, please contact Brian Lundin, Esquire, of Lundin Law PC, at 888-713-1033, or via email at [email protected]. The investigation will focus on whether the Company failed to disclose that: (i) Anavex had used a paid stock promoter to artificially inflate the Company's share price; and (ii) as a result of the foregoing, Anavex's public statements were materially false and misleading at all relevant times. No class has been certified in the above action. Until a class is certified, you are not considered represented by an attorney. You may also choose to do nothing and be an absent class member. Lundin Law PC was created by Brian Lundin, a securities litigator based in Los Angeles. This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.
View source version on businesswire.com: http://www.businesswire.com/news/home/20160205005904/en/ |
